Trial
NCT03639610
PK of Melphalan During Treatment With Melflufen and Dexamethasone in Patients With RRMM and Impaired Renal Function
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Oncopeptides AB
Collaborators
—
Condition
Renal Impairment
Intervention
Melflufen
Why stopped
The sponsor decided to terminate the study following an FDA request of a partial clinical hold.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-03-10